Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 16, 2023

BUY
$25.16 - $60.63 $15,096 - $36,378
600 Added 4.48%
14,000 $849 Million
Q1 2022

Apr 21, 2022

BUY
$30.27 - $49.22 $178,593 - $290,398
5,900 Added 78.67%
13,400 $490,000
Q4 2021

Feb 03, 2022

SELL
$42.11 - $73.26 $143,174 - $249,084
-3,400 Reduced 31.19%
7,500 $371,000
Q3 2021

Oct 21, 2021

SELL
$48.2 - $78.89 $120,500 - $197,225
-2,500 Reduced 18.66%
10,900 $776,000
Q2 2021

Aug 13, 2021

SELL
$21.63 - $57.65 $15,141 - $40,355
-700 Reduced 4.96%
13,400 $689,000
Q1 2021

Apr 30, 2021

SELL
$11.0 - $28.24 $4,400 - $11,296
-400 Reduced 2.76%
14,100 $354,000
Q4 2020

Feb 16, 2021

SELL
$10.12 - $13.94 $18,216 - $25,092
-1,800 Reduced 11.04%
14,500 $174,000
Q3 2020

Nov 12, 2020

BUY
$9.93 - $13.47 $13,902 - $18,858
1,400 Added 9.4%
16,300 $163,000
Q2 2020

Aug 12, 2020

BUY
$9.56 - $12.51 $43,976 - $57,546
4,600 Added 44.66%
14,900 $156,000
Q1 2020

May 12, 2020

BUY
$7.54 - $15.77 $77,662 - $162,431
10,300 New
10,300 $110,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $641M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.